Month: July 2026

Positions: None.

Citi projects that soaring memory prices will lead to widespread demand destruction, forecasting 2026 PC units falling 15% in 2026, and smartphones declining 12%.

— zerohedge (@zerohedge) July 9, 2026

Positions: None.

Positions: None.

Upside:

-AEHR +18% (receives follow-on FOX-XP wafer-level burn-in system order from lead silicon photonics customer)

-ALNY +18% (strength following disappointing Phase 3 CARDIO-TTRansform data from AZN, IONS)

-ENVX +17% (appoints Michael Vyvoda as COO)

-SMPL +15% (earnings, guidance)

-BBIO +11% (strength following disappointing Phase 3 CARDIO-TTRansform data from AZN, IONS)

-FCEL +11% (signs MoU with Siemens for fuel cell-based power generation collaboration)

-CECO +6.9% (JPMorgan Chase and Co Initiates CECO with Overweight, price target: $130)

-MU +6.7% (plans up to $3B investment to strengthen US semiconductor supply chain in collaboration with GlobalWafers)

-UCTT +6.5% (appoints Michael Keogh as CFO)

-BE +6.2% (rejects Hunterbrook Media report claims on financial results, accounting and scandium oxide supply)

-CBRS +5.8% (expands European data center capacity)

-MRVL +5.8% (sector strength)

-SNDK +5.1% (sector strength; hearing price target raise from Wedbush)

-TENX +5.1% (to present LEVEL trial data at ESC Congress 2026)

-NBIS +5.0% (strength following META headline on doubling compute capacity)

-INMD +4.8% (Steel Partners offers to acquire InMode at $16.75/shr in cash)

-PENG +4.6% (earnings, guidance)

-AVGO +4.4% (strength following META headline on doubling compute capacity)

-MARA +4.3% (acquires Matagorda County, Texas powered land site from HIF)

-CRWV +3.7% (strength following META headline on doubling compute capacity)

-AMD +3.5% (sector strength)

-CAT +3.0% (momentum)

-FIVE +2.4% (hearing Mizuho Securities Raised FIVE to Outperform from Neutral, price target: $220)

Downside:

-IONS -21% (Phase 3 CARDIO-TTRansform misses primary endpoint for eplontersen in ATTR-CM)

-FBRX -8.2% (FB102 Phase 1b vitiligo study data)

-AZN -7.8% (Phase 3 CARDIO-TTRansform misses primary endpoint for eplontersen in ATTR-CM)

-IBM -4.8% (SBUX reportedly uses AI to develop in-house software solutions to reduce reliance on Microsoft and IBM software)

-CRM -4.6% (KeyBanc Capital Markets Cuts CRM to Sector Weight from Overweight)

-RXT -4.1% (expands Palantir partnership for regulated and sovereign enterprise AI; files mixed shelf; indeterminate amount; earnings, guidance)

-LEVI -4.0% (earnings, guidance)

-META -3.8% (AI chip going to production)

-MAT -2.7% (Goldman Sachs Cuts MAT to Sell from Neutral, price target: $12)

-PEP -2.5% (earnings, guidance)

A pattern: Memory/semis up big, memory/semis down big, then up big….

Wash, rinse and repeat.

In the market without memory from day to day.

Great for dispassionate and opportunistic traders – not so great for the buy and hold crowd.

Positions: None.

US CANNABIS — PREMARKET BRIEF | Thu Jul 9

DEA's rescheduling hearing ends within 4 sessions.

Yesterday the opposition's own star witness conceded marijuana meets the Schedule III criteria.

Meanwhile the options market spent the week walking out of the room.

Thread 🧵 pic.twitter.com/GFEUGsAaO9

— Denis Rudev (@DenisRudev) July 9, 2026

Position: None

FYI: no ALJ/DEA hearing today as things are moving ahead of schedule. The next hearing day will be tomorrow, July 10th.

Great opportunity to do your due diligence today! $MSOS $TRLV $GLAS $CURA $TLRY $GTII $VRNO@CultivatedNews @ 10am@AdvisorShares @ 12pm@TheDalesReport @ 4pm pic.twitter.com/i1huuNTRcM

— Anthony (@Anthonys_Takes) July 9, 2026

Position: None